DAPA HF - The Dapagliflozin And Prevention Of Adverse-outcomes In Heart Failure Trial

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Hot Line Session 1 European Society of Cardiology, Other ESC Premium Access ESC Congress 2019

ESC 365 is supported by

ESC 365 is supported by